(redirected from CA 125)
Also found in: Dictionary, Medical, Acronyms, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to antigen

any substance (as a toxin or enzyme) that stimulates an immune response in the body (especially the production of antibodies)

References in periodicals archive ?
For women with ovarian cancer, CA 125 levels were found to correlate with tumour burden in 93% of cases.
Various alimentary canal and pelvic cancers have already been associated with the high concentrations of CA 125 in the blood8,9,15,16.
CA 125 levels were determined by the electrochemiluminescence immunoassay method using the DXI 800 automatic quantitative hematology analyzer (Beckman Coulter Inc., CA, USA).
Auge et al., "HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases," Tumor Biology, vol.
Judson, "Sarcoidosis associated with an elevated serum CA 125 level: description of a case and a review of the literature," The American Journal of the Medical Sciences, vol.
For a premenopausal woman who has not completed childbearing, transvaginal ultrasonography with serum CA 125 testing can be considered.
Dekker et al., "Fluctuations in CA 125 and CA 15-3 serum concentrations during spontaneous ovulatory cycles," Human Reproduction, vol.
Women cannot be screened for CA 125 levels until 35, but Janet argues this age limit should be lowered.
Irritable bowel-type symptoms and/or raised CA 125 levels do not necessarily mean you have ovarian cancer, as both of these can also be caused by other more benign conditions.
Among the tests being recommended for Arroyo are a PET scan and tumor marker tests such as alpha feto protein for the liver, varcinoembryonic antigen (CEA) for the breast and pancreas and CA 125 calcitonin for the medullary thyroid.
Serum CA 125 concentrations in patients with benign ovarian tumours.
Other diagnostic tests include a CA 125 blood test and a transvaginal ultrasound.
Results: The serum CEA and CA 125 levels were found to be significantly elevated in gastric cancer patients than in controls.
CA 15-3, CA 125, and [beta]-2 microglobulin are three common tumor markers currently used for diagnosis, prognosis, assessment of therapeutic response, and/or to evaluate recurrence in breast and ovarian cancer and malignant lymphoproliferative disorders, respectively.